These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2870471)

  • 21. 5-Oxoprolinal: transition-state aldehyde inhibitor of pyroglutamyl-peptide hydrolase.
    Friedman TC; Kline TB; Wilk S
    Biochemistry; 1985 Jul; 24(15):3907-13. PubMed ID: 2864952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyroglutamyl peptidase: an overview of the three known enzymatic forms.
    Cummins PM; O'Connor B
    Biochim Biophys Acta; 1998 Dec; 1429(1):1-17. PubMed ID: 9920379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A continuous fluorigenic assay for the measurement of the activity of endoplasmic reticulum aminopeptidase 1: competition kinetics as a tool for enzyme specificity investigation.
    Evnouchidou I; Berardi MJ; Stratikos E
    Anal Biochem; 2009 Dec; 395(1):33-40. PubMed ID: 19638272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of two fluorimetric assays for the determination of pyroglutamyl aminopeptidase type-II activity.
    Gallagher SP; O'Leary RM; O'Connor B
    Anal Biochem; 1997 Jul; 250(1):1-9. PubMed ID: 9234892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution and characterization of cyclo(His-Pro)-like immunoreactivity in the rat gastrointestinal tract.
    Mori M; Pegues J; Prasad C; Edwards RM; Wilber JF
    Biochem Biophys Res Commun; 1982 Dec; 109(3):982-7. PubMed ID: 6130766
    [No Abstract]   [Full Text] [Related]  

  • 26. Facile analysis and purification of deblocked N-terminal pyroglutamyl peptides with a strong cation-exchange sulfoethyl aspartamide column.
    Crimmins DL; McCourt DW; Schwartz BD
    Biochem Biophys Res Commun; 1988 Oct; 156(2):910-6. PubMed ID: 2903737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The substrate specificity of pyrrolidone carboxylyl peptidase from Bacillus amyloliquefaciens.
    Fujiwara K; Kobayashi R; Tsuru D
    Biochim Biophys Acta; 1979 Sep; 570(1):140-8. PubMed ID: 39608
    [No Abstract]   [Full Text] [Related]  

  • 28. A technique for the removal of pyroglutamic acid from the amino terminus of proteins using calf liver pyroglutamate amino peptidase.
    Podell DN; Abraham GN
    Biochem Biophys Res Commun; 1978 Mar; 81(1):176-85. PubMed ID: 26343
    [No Abstract]   [Full Text] [Related]  

  • 29. Purification of and kinetic studies on a narrow specificity synaptosomal membrane pyroglutamate aminopeptidase from guinea-pig brain.
    O'Connor B; O'Cuinn G
    Eur J Biochem; 1985 Jul; 150(1):47-52. PubMed ID: 2862039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of aminopeptidases in human kidney soluble fraction.
    Mantle D; Lauffart B; McDermott J; Gibson A
    Clin Chim Acta; 1990 Feb; 187(2):105-13. PubMed ID: 2317929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [L-pyrrolidone carboxylyl peptidase (author's transl)].
    Daisuke T; Kunio F
    Tanpakushitsu Kakusan Koso; 1980; 25(6):490-9. PubMed ID: 6111106
    [No Abstract]   [Full Text] [Related]  

  • 32. N-alpha-carbobenzoxy pyroglutamyl diazomethyl ketone as active-site-directed inhibitor for pyroglutamyl peptidase.
    Fujiwara K; Matsumoto E; Kitagawa T; Tsuru D
    Biochim Biophys Acta; 1982 Apr; 702(2):149-54. PubMed ID: 6123347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pyroglutamyl peptidase].
    Tsuru D
    Tanpakushitsu Kakusan Koso; 1983 Nov; 28(12):1349-54. PubMed ID: 6141621
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase on TRH degradation in rat serum.
    Friedman TC; Wilk S
    Biochem Biophys Res Commun; 1985 Oct; 132(2):787-94. PubMed ID: 2865955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminopeptidases: aminopeptidase M (EC 3.4.11.2), pyroglutamate aminopeptidase (EC 3.4.19.3), and prolidase (EC 3.4.13.9).
    Sweeney PJ; Walker JM
    Methods Mol Biol; 1993; 16():319-29. PubMed ID: 19082982
    [No Abstract]   [Full Text] [Related]  

  • 36. Bilateral distribution of aminopeptidase activities in selected structures of a photoneuroendocrine circuit and other rat brain areas.
    Ramirez M; Sanchez B; Arechaga G; Garcia S; Lardelli P; Venzon D; de Gandarias JM
    Exp Clin Endocrinol; 1992; 99(2):59-63. PubMed ID: 1353453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delineation of a particulate thyrotropin-releasing hormone-degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase.
    Friedman TC; Wilk S
    J Neurochem; 1986 Apr; 46(4):1231-9. PubMed ID: 2869108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrolysis of synthetic substrate, L-pyroglutamyl p-nitroanilide is catalyzed solely by pyroglutamyl aminopeptidase I in rat liver cytosol.
    Abe K; Watanabe N; Kosaka T; Yamada M; Tokui T; Ikeda T
    Biol Pharm Bull; 2003 Nov; 26(11):1528-33. PubMed ID: 14600395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyroglutamyl diazomethyl ketone: potent inhibitor of mammalian pyroglutamyl peptide hydrolase.
    Wilk S; Friedman TC; Kline TB
    Biochem Biophys Res Commun; 1985 Jul; 130(2):662-8. PubMed ID: 2862865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of thyrotropin-releasing hormone in human cerebrospinal fluid. Isolation and characterization of pyroglutamate aminopeptidase activity.
    Prasad C; Jayaraman A
    Brain Res; 1986 Feb; 364(2):331-7. PubMed ID: 2868782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.